What makes us different
iMOST® (Instant Mobile Self-Test), first of the type, is based on outside-the-box thinking and a fundamentally different paradigm. The new paradigm is being realized through uniquely implementing nanotechnology, advance imaging, Nano-Enabled Artificial Intelligence/Machine-learning (NEAM) and new bio/chemical processes into diagnostic testing.
-
Nanotechnology
-
Advance Imaging
-
Nano-Enabled
Artificial intelligence -
New Bio/Chemistry
About us
At Essenlix, we are pioneering the future of health diagnostics with our groundbreaking iMOST platform. Our team, a dynamic and multidisciplinary group of experts from industry, healthcare, and academia, excels in bio-engineering, nanotechnology, advanced imaging, artificial intelligence, machine learning, and medicine. Essenlix was founded in 2013 by Dr. Stephen Y. Chou and Dr. Lin Chou. Dr. Stephen Y. Chou is one of the world’s leading nanotechnology experts, with deep experience in bioengineering, sensors, and clinical diagnostics. Lin Chou has been an internist for over 30 years.
